Nishino, M., Yoshikawa, T., Shoji, H., Fujisaki, Y., Ogawa, R., Wada, T., Hayashi, T., Yamagata, Y., Seto, Y. (2025). SOX/FOLFOX+nivolumab followed by conversion surgery for HER2 negative primary gastric or gastroesophageal junction cancer with oligo-metastasis or borderline resectable tumors: Early results of a consecutive 41 cases.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.487